Julianne Turner is a corporate associate in the Boston office of Kirkland & Ellis LLP. Her practice focuses on mergers and acquisitions for public and private companies primarily in the pharmaceutical and biotechnology industries.
Experience
Representative Matters
Amicus Therapeutics in its $4.8 billion sale to BioMarin
Akero Therapeutics in its sale to Novo Nordisk for up to $5.2 billion
More
Credentials
Admissions & Qualifications
2025Massachusetts
Education
University of Chicago Law SchoolJ.D.2025
Boston UniversityEd.M.2022
University of California, Los AngelesB.A., French & Historysumma cum laude2019
